BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 17, 2026
Home » Topics » In the clinic, BioWorld

In the clinic, BioWorld
In the clinic, BioWorld RSS Feed RSS

In the clinic for Aug. 1, 2023

Aug. 1, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications:4D, Annexon, Apellis, Biosion, Clearside, Enlivex, Ionis, Mymd, Natera, Regeneron, Sunovion, Taysha, Tonix, Ultragenyx.
Read More

In the clinic for July 31, 2023

July 31, 2023

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Belite, Chinook, Cullgen, Genenta, Homology, Immutep, IO Biotech, Merck, Synthekine.


Read More

In the clinic for July 28, 2023

July 28, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aquestive, Astrazeneca, Avenue, Checkpoint, Daiichi Sankyo, Disc, Eli Lilly, Eyepoint, Glyscend, Lipocine, Maat, Merck & Co., Mersana, Newamsterdam, Synthekine Takeda, Telavant, Tonix, Urogen.
Read More

In the clinic for July 27, 2023

July 27, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Alterity, Amytrx, Essex, Humacyte, Karyopharm, Merck & Co., Moderna, Newamsterdam, Nymox, Organicell, Oryzon, Pharmabcine, Viage.
Read More

In the clinic for July 26, 2023

July 26, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ascletis, Compass Pathways, Elevar, Epsilogen, Gilead Sciences, Hoth, Immuron, Intrommune, Mindbio, Moonlake Immunotherapeutics, Remegen, Stoke, Third Harmonic.
Read More

In the clinic for July 25, 2023

July 25, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Bavarian, Belite, Biomea, CG, Crescendo, Cybin, Dyadic, Eagle, Gilead, Horizon, Kodiak, Lineage, Panbela, Paxmedica, Recce, Sunho, Syndax, Tango.
Read More

In the clinic for July 24, 2023

July 24, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: ADC, Elucida Oncology, Promontory, Tonix, Triastek.
Read More

In the clinic for July 21, 2023

July 21, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biocity, Biogen, Bright Minds, Bond, Gannex, Geovax, Grifols, Harmony, Nanobiotix, Palvella, Perfuse, Pfizer, Sathgen, Vir.
Read More

In the clinic for July 20, 2023

July 20, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Armgo, Emergex, Faron, Hansa, Kintor, Merck & Co., Recce, Telix, Zai, Zambon.
Read More

In the clinic for July 19, 2023

July 19, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D Molecular, Antengene, Aptevo, Calidi, Camurus, Corcept, ENB, Engrail, Grifols, Irlab, Janssen, Mineralys, Neumora, Ocuterra, Revolo, Xylocor.
Read More
Previous 1 2 … 63 64 65 66 67 68 69 70 71 … 161 162 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 16, 2026.
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 14, 2026
  • Cancer cell in the cross-hairs

    Selective CBL-B inhibitor with improved safety profile disclosed

    BioWorld Science
    CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
  • MSD discloses new HCN1/2 blockers

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing